Ventilator Associated Pneumonia clinical trials

Explore recruiting ventilator associated pneumonia clinical trials.

Recruiting ventilator associated pneumonia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ventilator Associated Pneumonia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit. Multicentric non-inferiority randomised controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

ASPIC - Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia

Portugal, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Human recombinant interferon gamma in the treatment of ventilator-acquired pneumonia in ICU patients. IGNORANT study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

EaRly impAct theraPy with ceftazidime-avibactam via rapID diagnostics versus standard of care antibiotics and diagnostics in patients with bloodstream infection, hospital-acquired pneumonia or ventilator-associated pneumonia due to Pseudomonas aeruginosa or carbapenemase producing Enterobacterales ("RAPID")

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Ventilator Associated Pneumonia trials by city

Ventilator Associated Pneumonia in Toronto Ventilator Associated Pneumonia in Vancouver Ventilator Associated Pneumonia in Montreal Ventilator Associated Pneumonia in Calgary Ventilator Associated Pneumonia in Edmonton Ventilator Associated Pneumonia in Ottawa Ventilator Associated Pneumonia in Winnipeg Ventilator Associated Pneumonia in Quebec City Ventilator Associated Pneumonia in Hamilton Ventilator Associated Pneumonia in Kitchener Ventilator Associated Pneumonia in London Ventilator Associated Pneumonia in Halifax Ventilator Associated Pneumonia in New York Ventilator Associated Pneumonia in Los Angeles Ventilator Associated Pneumonia in Chicago Ventilator Associated Pneumonia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease